Single-use Bronchoscopes Market Revenue to Attain USD 1,132.06 Mn by 2035


Published: 23 Feb 2026

Author: Precedence Research

Share: linkedin twitter facebook

The global single-use bronchoscopes market revenue was valued at USD 482.16 million in 2025 and is expected to attain around USD 1,132.06 million by 2035, growing at a CAGR of 8.915% during forecast period.The market is significantly growing due to the shift toward hygienic medical procedures, increased prevalence of respiratory illness, and a strong focus of hospitals on eliminating cross-contamination risks related to reusable scopes.

Single-use Bronchoscopes Market Revenue Statistics

What are the Major Factors Driving the Single-Use Bronchoscopes Market?

The market is primarily driven by the rising prevalence of respiratory diseases such as lung cancer and COPD, increasing emphasis on patient safety, and the need to improve procedural efficiency while reducing sterilization costs. Regulatory scrutiny around endoscopy reprocessing and infection risks has further accelerated the adoption of safer alternatives, especially for frequent diagnostic and therapeutic bronchoscopy procedures. Single-use scopes eliminate the need for complex and costly sterilization processes, significantly supporting global market growth.

Segment Insights

  • By Usage, The ICUs segment held the largest market share in 2025 due to the critical role played by such devices in the ICUs, with safety and hygiene, which helps mitigate the cross-contamination risk between patients, especially patients with respiratory illness.
  • By Indication, The lung cancer sector dominated the market with the largest share in 2025, owing to the increasing lung cancer cases worldwide that led to the rapid surge in demand for safe and fast-acting treatment options.
  • By End Use, The outpatient facilities segment dominated the market in 2025 due to the growing shift toward minimally invasive procedures performed in ambulatory and day-care settings.

Meanwhile, the hospitals segment is growing in the market, as these facilities are often equipped with the necessary devices and advanced technologies for respiratory diseases, and a large pool of patients prefer hospitals as the primary care center for better outcomes and effective treatment options, as per individuals' medical needs and history.

Regional Insights

North America accounted for the largest share of the single-use bronchoscopes market in 2025, driven by the rising prevalence of respiratory diseases requiring isolated and infection-controlled treatment. Growing demand for disposable medical devices to prevent cross-contamination, along with supportive government initiatives promoting infection control and sustainable healthcare solutions, further strengthened regional adoption. At the country level, the U.S. leads the market with advanced healthcare infrastructure, well-equipped hospitals, and rapid adoption of innovative medical technologies.

Asia Pacific is expected to register the fastest CAGR during the foreseeable period due to the increasing prevalence of respiratory illness, including lung disorders, a growing geriatric population that is highly prone to encountering such diseases, and a robust healthcare infrastructure that supports clean and hygienic disposable medical devices. On a country level, China is largely contributing to the market due to the increasing number of medical device manufacturing companies.

Single-use Bronchoscopes Market Coverage

Report Attribute Key Statistics
Market Revenue in 2025 USD 482.16 Million
Market Revenue by 2035 USD 1,132.06 Million
CAGR from 2026 to 2035 8.915%
Quantitative Units Revenue in USD million/billion, Volume in units
Largest Market North America
Base Year 2025
Regions Covered North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa

Recent Development

  • In February 2026, the leading pharma company, Zydus Lifesciences, launched India’s first affordable oscillating positive expiratory pressure device called PEPAIR with an advanced system to support mucous clearance and enhance air pathways in nostril for patients with COPD, Asthma, and Bronchiectasis. (Source: https://www.expresspharma.in)

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/7725

You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344

Related Reports